Description

Pharmaceutical Brand Briefings offers unique consumer insights from MedTrackAlert's 700,000+ members on the leading prescription drug brands. MedTrackAlert is a consumer health information company dedicated to helping people better understand the scope of their chronic diseases and conditions, as well as the benefits and risks of associated medications. MedTrackAlert provides its members with free, important, time-sensitive news to keep them aware of advances, adverse drug interactions, and potential dangers related to their chronic disease states and medication use. MedTrackAlert's data is derived from consumer interest in news stories presented by the company to those who subscribe to their email newsletters. The prescription drug brands included in the Anti-Arthritis Drugs Pharmaceutical Brand Briefings include Celebrex, Enbrel, HUMIRA and REMICADE.

Table of Contents

Executive Summary - pgs. 4-6 Celebrex - Pfizer - pgs.7-8 Enbrel - Amgen/Wyeth - pgs. 9-10 HUMIRA - Abbott Laboratories - pgs. 11-12 REMICADE - J&J/Schering-Plough - pgs. 13-14